Relay Therapeutics, Inc.

RLAY ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $1.10B

Liabilities Breakdown FY2022

Total Liabilities: $149.6M